Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Elixinol Wellness ( (AU:EXL) ) has shared an update.
Elixinol Wellness Ltd announced a late lodgement of Appendix 3Y due to an administrative oversight related to a change in director’s interest. The company has acknowledged its obligations under ASX Listing Rules and has implemented measures to improve its internal processes to ensure future compliance, reflecting its commitment to transparency and regulatory adherence.
More about Elixinol Wellness
Elixinol Wellness Limited (ASX: EXL) is a prominent player in the global hemp industry, focusing on the innovation, marketing, and sale of hemp and other plant-derived food, skincare, and nutraceutical products. The company operates a vertically integrated business in Australia, offering products across human nutrition, human wellness, pet wellness, and superfood ingredients under various brands. Elixinol USA also markets high-quality hemp and plant-derived products.
YTD Price Performance: -55.26%
Average Trading Volume: 449,909
Technical Sentiment Signal: Sell
Current Market Cap: A$3.91M
For an in-depth examination of EXL stock, go to TipRanks’ Overview page.